Aesica Forms Manufacturing Partnership with Noramco for Codeine API

Aesica has entered a manufacturing partnership with Noramco to provide the UK market with an alternative source of codeine API.

Aesica, a UK-based developer and manufacturer of active pharmaceutical ingredients, has inked a manufacturing agreement with Noramco, a global manufacturer and supplier of opiate-derived APIs, to provide the UK market with an alternative source of codeine API.

The two companies have formed an integrated value chain comprising raw material supply security, technical excellence, production facilities and regulatory expertise. Noramco will sell codeine manufactured by Aesica through its European-based sales team.
 
The alliance involves a technical transfer for the manufacture of codeine phosphate from a patented poppy supplied by Noramco’s sister company, Tasmanian Alkaloids.